These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up. Baethge C, Gruschka P, Berghöfer A, Bauer M, Müller-Oerlinghausen B, Bschor T, Smolka MN. J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479 [Abstract] [Full Text] [Related]
4. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression. Ketter TA, Post RM, Parekh PI, Worthington K. J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374 [Abstract] [Full Text] [Related]
5. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients. Placidi GF, Lenzi A, Lazzerini F, Cassano GB, Akiskal HS. J Clin Psychiatry; 1986 Oct; 47(10):490-4. PubMed ID: 3093468 [Abstract] [Full Text] [Related]
10. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder. Goodwin FK. J Clin Psychiatry; 2003 Oct; 64 Suppl 5():18-24. PubMed ID: 12720480 [Abstract] [Full Text] [Related]
11. Carbamazepine as adjunct or alternative to lithium in the prophylaxis of recurrent affective disorders. Fritze J, Beneke M, Lanczik M, Schneider B, Walden J. Pharmacopsychiatry; 1994 Sep; 27(5):181-5. PubMed ID: 7838887 [Abstract] [Full Text] [Related]
12. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine]. Dardennes R, Lafuma A, Watkins S. Encephale; 1999 Sep; 25(5):391-400. PubMed ID: 10598301 [Abstract] [Full Text] [Related]